Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Atkins, A. Wilkes, O. Twentyman (Norwich, United Kingdom). Pulmonary function in sarcoidosis: A review of 85 cases using percentage predicted and lower limit of normal values to determine pattern of pulmonary function deficit. Eur Respir J 2011; 38: Suppl. 55, 915

Member's Comments

No comment yet.

Related content which might interest you: Change in pulmonary function abnormalities in sarcoidosis over time: A review of 75 cases Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012 Reference values for lung function: past, present and future Source: Eur Respir J 2010; 36: 12-19 Year: 2010 What is abnormal lung function in an elderly cohort? A comparison of the fixed ratio to the lower limit of normal ratio Source: Annual Congress 2006 - Highlights of epidemiology of COPD and lung function Year: 2006 High « red cell distribution width » levels can predict  pulmonary embolism risk in multiple trauma patients: a case control study. Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018 The impact of a new reference value set for diffusing capacity for patients with idiopathic pulmonary fibrosis. Source: International Congress 2018 – Quality, reference values and standards Year: 2018 The accuracy of FEF25-75/FVC for primary classification of pulmonary function test Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 The absolute values of extravascular lung water content as a criterion in the evaluation of the functional operability of patients with progressive pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 The clinical value of trend reports in pulmonary function testing Source: International Congress 2015 – CC5 Interpretation of pulmonary function testing Year: 2015 The use of FENO in COPD: the relationship to pulmonary function tests and its importance in differential diagnosis. Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Predicting IPF outcomes: lung function evaluation by %predicted and z-score Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Absolute values of the 6 minute walk distance are equally good to predict disease severity in pulmonary hypertension as percent predicted formulas Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Evaluation of high sensitivity C reactive protein in patients of bronchial asthma and its correlation with exacerbation rate and pulmonary function Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 The TLNO/TLCO ratio in pulmonary function test interpretation Source: Eur Respir J 2014; 43: 311 Year: 2004 The TLNO/TLCO ratio in pulmonary function test interpretation Source: Eur Respir J 2014; 43: 310 Year: 2004 Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Accuracy of the calculated estimated postoperative pulmonary function (CEPPF) in lung cancer patients Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007 The comparison study on the effects of high versus low flux membrane on pulmonary function tests in hemodialysis patients Source: Annual Congress 2012 - Predicting the future: the impact of reference values on a range of respiratory paramaters Year: 2012 Prognostic value of modified classification based on lung function tests in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 Diagnosis of chronic lung allograft dysfunction using absolute values and percentages predicted Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017